Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fasting Condition

NCT01888250 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Lamotrigine

Sponsor

Dr. Reddy's Laboratories Limited